Jacob Chacko - May 11, 2022 Form 4 Insider Report for Oric Pharmaceuticals, Inc. (ORIC)

Role
President and CEO, Director
Signature
/s/ Christian Kuhlen, attorney-in-fact
Stock symbol
ORIC
Transactions as of
May 11, 2022
Transactions value $
$1,288,597
Form type
4
Date filed
5/13/2022, 06:52 PM
Previous filing
Mar 25, 2022
Next filing
May 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORIC Common Stock Purchase $884K +305K +86.37% $2.90 657K May 11, 2022 Direct F1
transaction ORIC Common Stock Purchase $190K +69.4K +10.55% $2.75 727K May 12, 2022 Direct F2
transaction ORIC Common Stock Purchase $215K +76.1K +10.47% $2.82 803K May 13, 2022 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 304,574 shares purchased in the price range of $2.695 to $2.95 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F2 Represents the weighted average share price of an aggregate total of 69,354 shares purchased in the price range of $2.70 to $2.77 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F3 Represents the weighted average share price of an aggregate total of 76,072 shares purchased in the price range of $2.79 to $2.93 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.